Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2.

With President Donald Trump’s tariffs now in place, industry groups are warning that the move could hamstring U.S. pharmaceutical supplies and productivity.

Sen. Bill Cassidy, chair of the Senate HELP Committee, and ranking member Bernie Sanders were aligned on their concerns about RFK Jr.'s approach to vaccines. With a vote on RFK Jr.’s nomination to take place in the Senate Finance Committee next week, Cassidy, who also sits on that committee, said he’s going to have to use the weekend to make up his mind.

A sugar produced by soil bacteria may be able to stop the loss of skin pigment caused by vitiligo. A new study found that injecting the molecule into mice with the autoimmune disease slowed the rate of the rodents’ pigment loss and boosted the amount of pigment-protecting T cells.

Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in positive trial results that could set it up for a full approval.